甲基马逐渐减少与儿童难治的格雷夫斯病之间的关联
Sung Eun Kim1, Su Jin Park2, Soo Yeun Sim2
1Department of Pediatrics, College of Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
概括
在早期的格雷夫斯病 (GD) 中难以逐渐降低甲基马的剂量预测了难以治愈的病例. 早期囊和高甲状腺刺激激素受体抗体水平也表明小儿GD患者的预后不佳.
科学领域:
- 内分泌学 在内分泌学.
- 儿科内分泌学 儿科内分泌学
- 临床研究 临床研究
背景情况:
- 格雷夫斯病 (GD) 是一种自身免疫性疾病,需要长期管理.
- 识别难治性胃肠炎的因素对于优化治疗策略至关重要.
- 儿科GD在实现疾病缓解方面提出了独特的挑战.
研究的目的:
- 确定儿科患者难治的格雷夫斯病的预测因素.
- 分析甲基马 (MZ) 缩小速度和GD缓解率之间的关系.
- 确定与治疗耐药性相关的临床和生化标志物.
主要方法:
- 在10年的时间里,对93名儿科GD患者进行了回顾性分析.
- 计算"逐渐减速"用于调整甲基马 (MZ) 的剂量.
- 多变量逻辑回归用于识别难治性GD的独立预测因子.
主要成果:
- 28%的患者实现了缓解,而72%的患者有难以治疗的GD.
- 的频率更高 (p=0.031) 在坚持不移的组.
- 较慢的MZ缩小速度 (OR=0.598,p=0.006),的存在 (OR=4.706,p=0.017) 和提升的TSH受体抗体标位 (OR=1.032,p=0.034) 预测了难以治愈的GD.
结论:
- 在前四个月内难以逐渐降低甲基马的剂量是难治性GD的独立预测因素.
- 喉和提升的TSH受体抗体水平是与治疗耐药性相关的重要因素.
- 这些发现有助于早期识别和管理患有持续格雷夫斯病风险的儿科患者.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
01:20Synthesis and Regulation of Thyroid Hormones
4.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.3K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
01:20Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
01:24Antiasthma Drugs: Methylxanthines
203
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
203